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Summary: From the study described in part 1 of this series (Passing, H. et al. (1981), this j. 19,1137-1144) it has
been derived in part 3 (Passing, H. (1981), this j. 19, 1153-1166) that 6 reference laboratories are appropriate for the
establishment of assigned values and their uncertainty intervals in a control serum. From the same study the two out-
standing characteristics of an optimized design are found: It is sufficient that each reference laboratory performs single
determinations within independent series. The number of series however has no relevant influence on accuracy and pre-
cision of the assigned values. The following design is obtained: Six reference laboratories perform single determinations
in five independent series each. Additionally, the complete concept of establishment of assigned values is summarized.
Up to now, the model has met the expectations in practice.
Ein optimierter Meßplan für die Ermittlung von Sollwerten in Kontrollseren
Ermittlung von Sollwerten in Kontrollseren, IV.
Zusammenfassung: Von der in Teil l (Passing,H. et al. (1981) this j. 19,1137-1144) dieser Reihe beschriebenen Studie
wurde in Teil 3 abgeleitet (Passing, H. (1981) this j. 19, 1153-1166), daß zur Ermittlung von Sollwerten und Soll-
bereichen eines Kontrollserums 6 Referenzlabors angemessen sind. Von derselben Studie werden die beiden noch aus-
stehenden Charakteristika eines optimierten Meßplanes gefunden: Es reicht aus, daß jedes Referenzlabor Einfachbe-
stimmungen in unabhängigen Serien durchführt. Jedoch beeinflußt die Anzahl der Serien die Richtigkeit und Präzision
des Sollwertes nicht relevant. Man erhält folgenden Meßplan: Sechs Referenzlabors führen jeweils Einfachbestimmungen
in fünf unabhängigen Serien durch. Darüber hinaus wird das gesamte Sollwertermittlungskonzept zusammengefaßt. Bis
heute hat das Modell die gesetzten Erwartungen in der Praxis erfüllt.
Introduction The number of independent series per laboratory and
the number of replicate determinations within series.
This paper is the immediate continuation of I.e. (3). Two
problems are to be dealt with jointly: First, how to It was our intention (2) to investigate the influence of
evaluate the assigned value of a control serum and its different designs in order to elaborate a model which
uncertainty interval, and secondly, how to define an opti- gives accurate assigned values for acceptable expendi-
mized design. An appropriate distribution-free evaluation ture, resulting in a high degree of security. Security is
procedure has already been derived (3). used here in the sense of avoiding difficulties or legiti-
mate complaints with respect to recovery of assigned
Moreover, six laboratories have been shown to be appro--
 vaiUeS. This idea leads to an optimized design. Our
priate to an actual establishment of assigned values. Two
 model obtained in I.e. (2, 3,4) and in the present paper
further characteristics of the design are still undefined:
 is sujnmarized. It is compared with other models for
x) A preliminary report is given in I.e. (1) the establishment of assigned values, cf. I.e. (5,6, 7).
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Materials and Methods
The data of the study performed by laboratories of members
of the Verband der Diagnostica- und Diagnosticager te-
Hersteller (VDGH, Association of Diagnostics and Diagnostics
Instrumentation Manufacturers) (2) formed the experimental
basis. The study covered the constituents creatinine, glucose,
urea, alanine and aspartate aminotransferase2), creatine kinase2),
and 7-glutamyltransferase2). For each constituent we had 9 to 11
laboratories (see table 1) each having performed double determi-
nations in approximately 18 independent series of the unknown
sample, of the known control, and of a blind control. But we
processed only the first 15 series of the unknown sample which
had met the respective validity criterion as given in I.e. (4).
From these data we simulated various designs. As a conse-
quence of the results obtained in I.e. (3) we restricted our-
selves to all designs consisting of
1 = 6 laboratories,
J = 4,5,7,10 or 15 series,
K = 1 or 2 determinations per series.
For each such design several selections of 6 out of Imax3)
laboratories were randomly performed thus yielding a total
set of randomizations. The number T of these individual
randomization steps is given in table 1. The first J valid series
were used, and for K = 1 we used the first values only of the
double determinations thus simulating single determinations.
For details see I.e. (3).
The assigned value arid its uncertainty interval based on the
respective design and randomization are evaluated according
in the following procedure4). The data of K determinations
each within J series out of 6 laboratories are sorted. The total
number of available values is then n = 6 · J- K. From n we derive
m = 5 n/100 which is rounded off. m of the n values are trunc-
ated so that the range of the remaining values is as short as
possible. The extreme values of the remaining ones are the
uncertainty limits. The median of the remaining values is the
assigned value. This procedure has been shown to be superior
(3).
We computed two objective quantities for each design and
each randomization:
- The assigned value, and
- the width of its uncertainty interval.
Especially for I = Imax, J = 15, and K = 2 the assigned value
is called the reference assigned value (3). The reference
Tab. 1. Number T of replications of individual randomization
steps.
Constituent In
Creatinine
Glucose
Urea
Alanine aminotransferase
Aspartate aminotransferase
Creatine kinase
7-Glutamyltransferase
9
9
9
11
11
9
9
11
12
11
65
66
11
12
a) number of laboratories underlying this study.
2) Enzymes: Glutamate-pyruvate-transaminase = alanine amino-
transferase = £-alanine: 2-oxoglutarate aminotransferase, EC
2.6.1.2;glutamate-oxalacetate-transaminase = aspartate amino-
transferase = //-aspartate: 2-oxoglutarate aminotransferase, EC
2.6.1.1;7-glutamyltransferase = (5-glutamyl)-peptide: amirio-
acid 5-glutamyltransferase, EC 2.3.2.2; creatine kinase = ATP:
creatine N-phosphotransferase, EC 2.7.3.2.
3) Imax depends on the respective constituent and is identical to
the number of laboratories underlying this study, see table 1.
4) Called procedure 2 in I.e. (3).
assigned value and its uncertainty interval are used as reference
quantities.
The distribution of the results of all individual randomization
steps is plotted against J for K = 1 and K = 2. The judgement
of plots is based on criteria concering primarily robustness and
secondarily accuracy. Robustness is defined by the shape of the
respective distribution by means of three properties: The
distribution should be unimodal and non-uniform on both
sides of the mode whereas the location of the mode is arbitrary.
Secondly, the distribution should be connected. Thirdly, it
should have a small variation. Accuracy however relates to
good concordance of the median of the distribution with the
reference assigned value of the width of its uncertainty inter-
val, respectively. The judgement is performed by giving scores
2, l ,orO:
Score 2
The results of the simulation show high robustness and good
concordance except for at most one for T«» 12 or at most five
for T « 66 randomizations. Concordance is called good if the
median of the distribution of assigned values differs from the
reference assigned value by less than one in the last relevant
decimal place given by the respective analytical method. As
to the widths, concordance is called good if the median of the
distribution of the widths differs from the width of the uncer-
tainty interval of the reference assigned value by about 8% or
less, cf. I.e. (3).
Score 1
The results of the simulation show sufficient robustness whereas
their concordance may be less.
Score 0
The results of the simulation do not show sufficient robustness.
The scores are summed up over all constituents.
The scores are not based on additional quantitative criteria since
the definition of robustness cpvers several aspects. But by comp^
aring 10 distributions (J = 4, 5, 7,10, 15 for K> 1, 2) of each
objective quantity and each constituent the scores are given
simultaneously and relatively to each other in order to keep the
subjective influence down and to obtain a correct ranking. This
influence is also diminished by summing up the scores.
We focus our attention on designs covering 5 series at most in
order that the number of series is less than the number of labor^
atories (=6). Therefore, out of all designs covering 5 series at
most the design yielding the largest sum of scores is the best one.
By this methodological approach we arrive at an optimized
design. The sum of scores of the other designs (J > 7) gives an
empirical assessment of whether the limitation to J < 5 being
theoretically motivated is justified.
Results
Figures 1 to 7 show the distribution of assigned values
and their percentage deviation from the reference
assigned value as obtained from the individual randomi-
zation steps. The judgement of each figure is given in
table 2.
The judgement of figure 1 is described in.detail. The
median of 9 out of 10 distributions of creatinine varies
between 309.5 and 310.5 ìôçïú/É where 310 ìôçïÀ/l is
the reference assigned value. So the criterion of concord-
ance is fulfilled here. The distributions accQ^ding to
J = 4 and J = 7 series have the smallest variation when
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Fig. 1. Creatinine: Distribution of all assigned values and their percentage deviation from the reference assigned value as obtained
from T individual randomization steps, cf. table 1.
Plotter printout
Left ordinate: Creatinine [ìðéïÀ/À].
Right ordinate: Deviation [%).
Abscissa: Series no.
The upper plot is based on the first values only (K = 1), the lower one on both values of the double determinations (K = 2).
For each number of series used during the simulation each individual assigned value is marked by a star. The median of each
distribution is marked by o. The horizontal dashed lines give the reference assigned value. For K = 2 and 15 series the median
and the dashed line need not coincide because six laboratories only are involved here.
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Fig. 2. Glucose: Distribution of all assigned values and their percentage deviation from the reference assigned value as obtained from
T individual randomization steps, cf. table 1.
Plotter printout
Left ordinate: Glucose [mmol/1].
Right ordinate: Deviation [%}.
Abscissa: Series no.
For details see figure 1.
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Fig. 3. Urea: Distribution of all assigned values and their percentage deviation from the reference assigned value as obtained from T
individual randomization steps, cf. table 1.
Plotter printout
Left ordinate: Urea [mmol/lj.
Right ordinate: Deviation {%].
Abscissa: Series no.
For details see figure 1.
Fig. 4. Alanine aminotransferase: Distribution of all assigned values and their percentage deviation from the reference assigned value
as obtained from T individual randomization steps, cf. table 1.
Plotter printout
Left ordinate: Alanine aminotransferase [U/1J.
Right ordinate: Deviation [%}.
Abscissa: Series no.
For details see figure 1.
Fig. 5. Aspartate aminotransferase: Distribution of all assigned values and their0percentage deviation from the reference assigned value
as obtained from T individual randomization steps, cf. table 1.
Plf\tto»r T*rtntrk»itPlotter printout
Left ordinate: Aspartate aminotransferase [U/1J.
Right ordinate: Deviation \%\.
Abscissa: Series no.
For details see figure 1.
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Fig. 6. Creatine kinase: Distribution of all assigned values and their percentage deviation from the reference assigned value as obtained
from Ô individual randomization steps, cf. table 1.
Plotter printout
Left ordinate: Creatine kinase [U/l],
Right ordinate: Deviation [%].
Abscissa: Series no.
For details see figure 1.
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Fig. 7. 7-Glutamyltransferase: Distribution of all assigned values and their percentage deviation from the reference assigned'value as
obtained from T individual randomization steps, cf. table 1.
Plotter printout
Left ordinate: ã-Glutamyltransferase [U/l].
Right ordinate: Deviation [%].
Abscissa: Series no.
For details see figure 1.
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Tab. 2. Scores of plots of figures 1 to 7a).
Constituent
Number of series
4 5 7 10 15 4 5 7 10 15
Creatinine
Glucose
Urea
Alanine aminotrans-
ferase
Aspartate aminotrans-
ferase
Creatine kinase
ã-Glutamyltrans-
ferase
Total
2
2
0
0
0
1
0
5
1
1
0
0
0
1
0
3
2
0
0
0
2
0
0
4
0
0
1
1
1
0
0
3
0
0
2
2
2
1
0
7
2
0
0
1
0
0
0
3
0
0
0
1
0
1
0
2
0
0
0
2
0
0
0
2
0
0
0
2
0
0
1
3
0
0
2
0
0
1
0
3
a) All distributions of each figure are compared simultaneously.
The meaning of the scores is given in Materials and Methods.
b) Using first values only (K = 1) or both values K = 2) of the
double determinations.
the first values only are used (K = 1) especially since by
our definition the assigned value of up to one individual
randomization step may be neglected. Moreover, these
two distributions are unimodal, not uniform, and con-
nected. The distributions according to J = 4, K = 1 and
J = 4, K = 2 are nearly identical. Consequently, the
score 2 is given to them. The median of the distribution
according to j = 5 and K = 1 is 311 ìôçïÀ/À and therefore
less concordant with the reference assigned value, and
this distribution is less sharply one-peaked resulting in
the score 1. All the other distributions have a larger
variation or are multi-peaked and obtain score 0.
It should be stressed here that all distributions to be
compared are derived from the same randomizations.
That is why differences between distributions are not
caused at random; rather they are caused by the various
designs and the data themselves.
For each number of series the distribution based on
first values only of the double determinations (K = 1)
turns out to be at least as good as the distribution based
on both values (K = 2).
Figures 8 to 14 show the distribution of widths of
the uncertainty intervals of the above assigned values
as obtained from the individual randomization steps.
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Fig. 8. Creatinine: Distribution of the widths pf the uncertainty intervals of the assigned values shown in figure 1; for details see there.
Plotter printout
Ordinate: Creatinine [ìðéïÀ/À].
Abscissa: Series no.
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Fig. 9. Glucose: Distribution of the widths of the uncertainty intervals of the assigned values shown in figure 2; for details see figure 1.
Plotter printout
Ordinate: Glucose [mmol/1].
Abscissa: Series no.
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Fig. 10. Urea: Distribution of the widths of the uncertainty intervals of the assigned values shown in figure* 3; for details see figure 1.
Plotter printout
Ordinate: Urea lmmol/11.
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Fig. 11. Alanine aminotransferase: Distribution of the widths of the uncertainty intervals of the assigned values shown in figure 4;
for details see figure 1.
Plotter printout
Ordinate: Alanine amin ï trans ferase (U/1J.
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Fig. 12. Aspartate aininotransferase: Distribution.of the widths of the uncertainty intervals of the assigned values shown in figure 5;
fpr details see figure 1.
Plotter printout
Ordinate: Aspartate aminotransferase [U/1J.
Abscissa: Series no.
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Fig. 13. Creatine kinase: Distribution of the widths of the uncertainty intervals of the assigned values shown in figure 6; for details
see figure 1.
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Fig. 14. T-Glutamyltransferase: Distribution of the widths of the uncertainty intervals of the assigned values shown in figure 7;for
details see figure 1.
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The judgement of these figures is given in table 3.
Tab. 3. Scores of plots of figures 8 to 14*).
Number of series
Using the sum of scores given in table 4 it cannot be
decided however which of the designs covering either 4
or 5 series is better. But tables 2 to 4 show no relevant
improvement of the distributions if the number of series
increases.
Constituent 4 5 7 10 15 4 5 7 10 15
Creatinine
Glucose
Urea
Alanine aminotrans-
ferase
Aspartate aminotrans-
ferase
Creatine kinase
Y-Glutamyltrans-
ferase
0
1
1
0
0
0
0
1
0
1
0
0
2
0
0
1
1
1
1
0
0
0
1
1
0
1
0
0
0
2
1
0
0
0
1
1
0
1
0
0
0
0
2
0
0
1
0
0
1
0
1
0
0
1
0
0
0
1
2
0
2
0
0
0
1
1
0
1
0
2
Total 2 4 4 4 2 4 2
a) see table 2 for explanations.
The distribution based on first values only (K = 1) is
roughly as good as the distribution based on both
values (K = 2). The sum of the scores of all figures is
given in table 4 showing that the distribution based on
first values only is at least as good as that one based on
both values. This statement holds in particular for those
designs with 5 series at most.
Tab. 4. Sum of scores of all figures.
Number of series
10 15 4 10 15
8 11
a) see table 2 for explanations.
Discussion
Consequences of the simulation
The distribution of the results of the simulation based
on first values only is at least as good as the distribution
based on both values. Therefore it can clearly be stated:
Single determinations within series are sufficient for the
establishment of assigned values. This conclusion is satis-
factory with respect to the analytical expenditure. It
confirms a result (2) from quite another point of view.
So we restrict ourselves to single determinations.
The judgement of figures does not give a decision for the
choice of the numbers J of series. The median and the
minimal and maximal values qf the plotted distributions
of the assigned values do not differ for varying J from a
practical point of view, except for creatine kinase.
There is often a trend to increasing widths when J is
enlarged. This fact is also theoretically expected at least
for small J. But the range of the widths of the uncertainty
intervals computed from 6 laboratories selected at
random does not contract in general if J increases, cf.
table 5. Therefore it must be concluded from our judge-
ment and from a practical point of view, too, that the
number J of series obviously does not influence the
accuracy and the precision of the assigned value for
J>4.
It is reasonable to restrict J to 5 at most a priori on the
following consideration. The accuracy and the precision
of the assigned value is influenced most by the variation
of accuracy between laboratories because in most cases
this variation is larger than the variation between series
or within series (4). Consequently, the number I of
laboratories involved should be larger than the number
Tab. 5. Range») of widths of uncertainty intervals using first values only of the double determinations.
Constituent
Creatinine
Glucose
Urea
Alanine aminotransferase
Aspartate aminotransferase
Creatine kinase
-ã-Glutamyltransferase
Number of series
4 5
14
0.3
0.5
5.1
4.6
38
1.5
17
0.3
0.4
4.9
4.9
19
2.2
7
27
0.3
0.6
3.9
2.3
25
1.4
10
20
0.2
0.3
4.7
1.4
37
1.5
15
18
0.2
0.2
4.3
2.0
38
1.2
unit
ìÀôéï1/1
mmol/1
mmol/1
U/l
U/l
U/l
U/l
a) Range refers to the difference of the largest and the smallest widths of uncertainty intervals computed from 6 laboratories
selected at random.
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J of series. In other words, large numbers of J cannot
refine the accuracy and the precision of the assigned
value for a fixed number of laboratories. This theoretical
consideration is confirmed by our simulation as stated
above. So it is reasonable to restrict the number of
series to J < 6. More than 5 independent series will not
yield more accurate and precise assigned values.
Since the results of the simulation do not differ essen-
tially for J = 4 and J = 5 we can be sure that J = 5 is
too large rather than too small. So we propose to perform
5 independent series. This is an acceptable experimental
expenditure which can be handled within one week.
We.have simulated balanced designs only i.e. an equal
number of series and of replicate determinations within
each reference laboratory was used. Yet, the variety of
other designs has not been studied. Therefore, the extent
to which accuracy and precision of the assigned value are
influenced cannot be assessed if an unequal number of
series or of replicate determinations within laboratories is
processed.
Discussion of criteria for judging plots
Each random selection of I laboratories out of our pool
of Imax laboratories corresponds to the participation of
certain I reference laboratories in the case of an actual
establishment of assigned values. Therefore, each assigned
value obtained from an individual randomization step
corresponds to an assigned value actually established. It
must be expected that approximately the same results
would be obtained if actually other laboratories parti-
cipated. Therefore, the distribution of the results of the
simulation depending on the reference laboratories in-
volved should be small and unimodal. A uniform distribu-
tion however would imply that each figure within a cer-
tain range can be obtained with equal probability as an
assigned value or as the width of its uncertainty interval.
An unconnected distribution consists of two partial
distributions being superposed but distinctly separated.
It indicates essential differences of accuracy or precision
between all available laboratories.
The idea of our criteria for judging the plots is to
distinguish those designs which are as robust as possible
against the effects just described. The criterion of con-
cordance has already been used (3). There it was dis-
cussed why concordance is weighed less than robustness.
The complete model
We summarize the results of all four papers of this series
to the following model.
Structure of the experiment
The project supervisor issues a blind control and the un-
known sample, assigned values of which are to be deter-
mined by six reference laboratories. Each reference
laboratory performs single determinations within five
valid (see below) independent series each containing
both sera and the internal quality control. A series and
thus the pertaining value of the unknown sample is found
valid by the project supervisor if the values of the internal
control as well as of the blind control of this series are
within the respective uncertainty intervals given by the
manufacturers. Additionally, the project supervisor may
perform other checks which may lead to the exclusion
of all values of a laboratory. For safety reasons he may
prescribe a larger number of series per laboratory or in-
volve more than six reference laboratories in order that
at least six laboratories each with five independent series
will pass the validity check. Then it may happen that
more than five series or even more than six laboratories
pass the validity checks.
Evaluation procedure for the unknown sample
An equal number (> 5) of valid values of each laboratory
is processed. If a laboratory performs more valid values
than another one so that its values cannot be processed
in total the values of the last valid series are neglected.
All permissible values of the laboratories are sorted. Out
of them the smallest or the largest value (i.e. about 5%
of all permissible values) is eliminated so that the range
of the remaining values is as small as possible5). Out of
these remaining values the median gives the assigned
value and the two extreme values give the limits of the
uncertainty interval.
Comparison with other models
Our design is in concordance with the NCCLS-design
(5) concerning the number of laboratories and of series.
But it covers an additional quality control of the data
by means of a blind control. Our evaluation procedure
however is distribution-free in contrast to the statistical
procedure (5). Moreover, we formally give a prediction
interval whereas a confidence interval is computed iii I.e. (5)
>»
The model in I.e. (6) covers three laboratories each with
double determinations within 15 or 10 independent
series depending on whether the sample is lyophilized or
liquid. The evaluation procedure is similar to ours. Both
techniques are distribution-free. They differ with respect
to the calculation of the assigned value only.
The model in I.e. (7) covers 10 laboratories each with
two values independently of the arrangement of these
two values. The statistical evaluation is based on a
normal distribution model. A prediction interval is
calculated in concordance with our procedure.
5) If actually more than 40 values are to be processed two of
them are truncated in an analogous manner, and so on. See
Materials and Methods.
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Both models (6, 7) do not employ a blind control.
The performance either of double determinations of
the unknown sample only or of single determinations
of the unknown sample and additionally of the blind
control results in the same analytical expenditure.
But it has been shown (2) that the blind control has
a greater control effect concerning elimination of
laboratories than has the double determination.
The boundary values of the number of laboratories
and of series used in the simulation were defined by
the numbers of the models (5,6,7). We started at
4 series however since two values only do not allow
an assessment of the accuracy of a laboratory.
Experiences up to now
The above model for the determination of assigned
values has been applied in practice for about two years;
so far, at least 3200 assigned values have been deter-
mined. There were no difficulties or legitimate com-
plaints with respect to recovery of assigned values.
Therefore, our optimized model has been proved to be
adequate. We can state that it gives a high degree of
security for acceptable expenditure.
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